Report Detail
Global Preventable Vaccines Market Insights and Forecast to 2026
- RnM4166239 |
- 26 August, 2020 |
- Global |
- 180 Pages |
- QYResearch |
- Pharma & Healthcare
Preventable Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Preventable Vaccines market is segmented into
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Segment by Application, the Preventable Vaccines market is segmented into
Bacterial Diseases
Virus Diseases
Regional and Country-level Analysis
The Preventable Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventable Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventable Vaccines Market Share Analysis
Preventable Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventable Vaccines business, the date to enter into the Preventable Vaccines market, Preventable Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
1 Study Coverage
- 1.1 Preventable Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Preventable Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Preventable Vaccines Market Size Growth Rate by Type
- 1.4.2 Adult Preventable Vaccines
- 1.4.3 Pediatric Preventable Vaccines
- 1.5 Market by Application
- 1.5.1 Global Preventable Vaccines Market Size Growth Rate by Application
- 1.5.2 Bacterial Diseases
- 1.5.3 Virus Diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Preventable Vaccines Market Size, Estimates and Forecasts
- 2.1.1 Global Preventable Vaccines Revenue 2015-2026
- 2.1.2 Global Preventable Vaccines Sales 2015-2026
- 2.2 Global Preventable Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Preventable Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Preventable Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Preventable Vaccines Competitor Landscape by Players
- 3.1 Preventable Vaccines Sales by Manufacturers
- 3.1.1 Preventable Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Preventable Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Preventable Vaccines Revenue by Manufacturers
- 3.2.1 Preventable Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Preventable Vaccines Revenue in 2019
- 3.2.5 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Preventable Vaccines Price by Manufacturers
- 3.4 Preventable Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Preventable Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Preventable Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Preventable Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Preventable Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Preventable Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Preventable Vaccines Revenue by Type (2015-2020)
- 4.1.3 Preventable Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Preventable Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Preventable Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Preventable Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Preventable Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Preventable Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Preventable Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Preventable Vaccines Revenue by Application (2015-2020)
- 5.1.3 Preventable Vaccines Price by Application (2015-2020)
- 5.2 Preventable Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Preventable Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Preventable Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Preventable Vaccines by Country
- 6.1.1 North America Preventable Vaccines Sales by Country
- 6.1.2 North America Preventable Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Preventable Vaccines Market Facts & Figures by Type
- 6.3 North America Preventable Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Preventable Vaccines by Country
- 7.1.1 Europe Preventable Vaccines Sales by Country
- 7.1.2 Europe Preventable Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Preventable Vaccines Market Facts & Figures by Type
- 7.3 Europe Preventable Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Preventable Vaccines by Region
- 8.1.1 Asia Pacific Preventable Vaccines Sales by Region
- 8.1.2 Asia Pacific Preventable Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Preventable Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Preventable Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Preventable Vaccines by Country
- 9.1.1 Latin America Preventable Vaccines Sales by Country
- 9.1.2 Latin America Preventable Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Preventable Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Preventable Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Preventable Vaccines by Country
- 10.1.1 Middle East and Africa Preventable Vaccines Sales by Country
- 10.1.2 Middle East and Africa Preventable Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Preventable Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Preventable Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description and Business Overview
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
- 11.1.5 GlaxoSmithKline Related Developments
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description and Business Overview
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Preventable Vaccines Products Offered
- 11.2.5 Merck Related Developments
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Description and Business Overview
- 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis Preventable Vaccines Products Offered
- 11.3.5 Novartis Related Developments
- 11.4 Pfizer
- 11.4.1 Pfizer Corporation Information
- 11.4.2 Pfizer Description and Business Overview
- 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Pfizer Preventable Vaccines Products Offered
- 11.4.5 Pfizer Related Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description and Business Overview
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi Preventable Vaccines Products Offered
- 11.5.5 Sanofi Related Developments
- 11.6 Takeda Pharmaceutical
- 11.6.1 Takeda Pharmaceutical Corporation Information
- 11.6.2 Takeda Pharmaceutical Description and Business Overview
- 11.6.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
- 11.6.5 Takeda Pharmaceutical Related Developments
- 11.7 Abbott
- 11.7.1 Abbott Corporation Information
- 11.7.2 Abbott Description and Business Overview
- 11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Abbott Preventable Vaccines Products Offered
- 11.7.5 Abbott Related Developments
- 11.8 Roche
- 11.8.1 Roche Corporation Information
- 11.8.2 Roche Description and Business Overview
- 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Roche Preventable Vaccines Products Offered
- 11.8.5 Roche Related Developments
- 11.9 AstraZeneca
- 11.9.1 AstraZeneca Corporation Information
- 11.9.2 AstraZeneca Description and Business Overview
- 11.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 AstraZeneca Preventable Vaccines Products Offered
- 11.9.5 AstraZeneca Related Developments
- 11.10 Mitsubishi Tanabe Pharma
- 11.10.1 Mitsubishi Tanabe Pharma Corporation Information
- 11.10.2 Mitsubishi Tanabe Pharma Description and Business Overview
- 11.10.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
- 11.10.5 Mitsubishi Tanabe Pharma Related Developments
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description and Business Overview
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
- 11.1.5 GlaxoSmithKline Related Developments
- 11.12 Serum Institute of India
- 11.12.1 Serum Institute of India Corporation Information
- 11.12.2 Serum Institute of India Description and Business Overview
- 11.12.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Serum Institute of India Products Offered
- 11.12.5 Serum Institute of India Related Developments
- 11.13 LG Life Sciences
- 11.13.1 LG Life Sciences Corporation Information
- 11.13.2 LG Life Sciences Description and Business Overview
- 11.13.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 LG Life Sciences Products Offered
- 11.13.5 LG Life Sciences Related Developments
- 11.14 S K Chemicals
- 11.14.1 S K Chemicals Corporation Information
- 11.14.2 S K Chemicals Description and Business Overview
- 11.14.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 S K Chemicals Products Offered
- 11.14.5 S K Chemicals Related Developments
- 11.15 Shenzhen Kangtai Biological Products
- 11.15.1 Shenzhen Kangtai Biological Products Corporation Information
- 11.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
- 11.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Shenzhen Kangtai Biological Products Products Offered
- 11.15.5 Shenzhen Kangtai Biological Products Related Developments
- 11.16 Sinovac Biotech
- 11.16.1 Sinovac Biotech Corporation Information
- 11.16.2 Sinovac Biotech Description and Business Overview
- 11.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Sinovac Biotech Products Offered
- 11.16.5 Sinovac Biotech Related Developments
- 11.17 Janssen Pharmaceuticals
- 11.17.1 Janssen Pharmaceuticals Corporation Information
- 11.17.2 Janssen Pharmaceuticals Description and Business Overview
- 11.17.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Janssen Pharmaceuticals Products Offered
- 11.17.5 Janssen Pharmaceuticals Related Developments
- 11.18 Crucell
- 11.18.1 Crucell Corporation Information
- 11.18.2 Crucell Description and Business Overview
- 11.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Crucell Products Offered
- 11.18.5 Crucell Related Developments
- 11.19 Bavarian Nordic
- 11.19.1 Bavarian Nordic Corporation Information
- 11.19.2 Bavarian Nordic Description and Business Overview
- 11.19.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Bavarian Nordic Products Offered
- 11.19.5 Bavarian Nordic Related Developments
- 11.20 Baxter
- 11.20.1 Baxter Corporation Information
- 11.20.2 Baxter Description and Business Overview
- 11.20.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Baxter Products Offered
- 11.20.5 Baxter Related Developments
- 11.21 Bharat Biotech
- 11.21.1 Bharat Biotech Corporation Information
- 11.21.2 Bharat Biotech Description and Business Overview
- 11.21.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Bharat Biotech Products Offered
- 11.21.5 Bharat Biotech Related Developments
- 11.22 Dynavax
- 11.22.1 Dynavax Corporation Information
- 11.22.2 Dynavax Description and Business Overview
- 11.22.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Dynavax Products Offered
- 11.22.5 Dynavax Related Developments
- 11.23 Bausch Health
- 11.23.1 Bausch Health Corporation Information
- 11.23.2 Bausch Health Description and Business Overview
- 11.23.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
- 11.23.4 Bausch Health Products Offered
- 11.23.5 Bausch Health Related Developments
- 11.24 Protein Sciences
- 11.24.1 Protein Sciences Corporation Information
- 11.24.2 Protein Sciences Description and Business Overview
- 11.24.3 Protein Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.24.4 Protein Sciences Products Offered
- 11.24.5 Protein Sciences Related Developments
- 11.25 Panacea Biotec
- 11.25.1 Panacea Biotec Corporation Information
- 11.25.2 Panacea Biotec Description and Business Overview
- 11.25.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
- 11.25.4 Panacea Biotec Products Offered
- 11.25.5 Panacea Biotec Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Preventable Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Preventable Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Preventable Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Preventable Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Preventable Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Preventable Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Preventable Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Preventable Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Preventable Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Preventable Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Preventable Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Preventable Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Preventable Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Preventable Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Preventable Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Preventable Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Preventable Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Preventable Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Preventable Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Preventable Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Preventable Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Preventable Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Preventable Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Preventable Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Preventable Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Preventable Vaccines. Industry analysis & Market Report on Preventable Vaccines is a syndicated market report, published as Global Preventable Vaccines Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Preventable Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
